Evaluation of OCTA following use of Anti VEGF in retinal disease of eye in diabetic patients
Not Applicable
- Conditions
- Health Condition 1: H350- Background retinopathy and retinalvascular changes
- Registration Number
- CTRI/2023/04/051257
- Lead Sponsor
- Maulana Azad Medical College
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients in the age group of 18-50 years with type 1 or 2 diabetes mellitus due to center involving diabetic macular edema (CFT of more than or equal to 300 micrometers) who are naive to treatment with anti VEGF
Subjects having best corrected visual acuity of atleast 6/60
Exclusion Criteria
Subjects having other significant ocular or systemic diseases like glaucoma, media opacity, optic atrophy other retinal diseases especially those which affect macular perfusion
Risk of thromboembolic events and/or occurence of these within past 6 months
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Changes in Optical coherence tomography angiography parameters following anti VEGF <br/ ><br>Foveal Avascular Zone <br/ ><br>Vessel density (Superficial capillary plexus , Deep capillary plexus, VD full)Timepoint: 1 month
- Secondary Outcome Measures
Name Time Method Changes in best corrected visual acuity following anti VEGF <br/ ><br>changes in Posterior segment Optical Coherence Tomography parameters(Central foveal thickness and sub foveal choroidal thickness) following anti VEGFTimepoint: 1 month